Nichtdepolarisierende Muskelrelaxanzien — Vorteile, Nachteile, Nebenwirkungen

Conference paper


In diesem Beitrag sollen zunächst die Vor- und Nachteile der nichtdepolarisierenden Relaxanzien als pharmakologische Gruppe kurz dargestellt werden. Im Anschluß daran werden die einzelnen Substanzen untereinander verglichen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Agoston S, Crul JF, Kersten UW, Scaf AHJ (1977) Relationship of the serum concentration of pancuronium to its neuromuscular activity in man. Anesthesiology 47: 509–512PubMedCrossRefGoogle Scholar
  2. 2.
    Ali HH, Savarese JJ, Basta SJ, Sunder N Gionfriddo M (1983) Evaluation of cumulative properties of three new non-depolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium. Br J Anaesth 55: 107S-1 IISGoogle Scholar
  3. 3.
    Andersen BN, Madsen JV, Schurizek BA, Juhl B (1988) Residual curarization: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand 32: 79–81PubMedCrossRefGoogle Scholar
  4. 4.
    Anttila P, Ertama P (1978) Relative potency of some neuromuscular blocking drugs in vivo and in vitro. Med Biol 56: 152–155PubMedGoogle Scholar
  5. 5.
    Arden JR, Lynam DP, Castagnoli KP, Canfell PC, Cannon JC, Miller RD (1988) Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 68: 771–776PubMedCrossRefGoogle Scholar
  6. 6.
    Astley BA, Hughes R, Payne JP (1987) Recovery of respiration after neuromuscular blockade with alcuronium. Br J Anaesth 59: 206–210PubMedCrossRefGoogle Scholar
  7. 7.
    Bach A, Layer M (1990) Muskelrelaxanzien zur Nierentransplantation: ein Vergleich zwischen Vecuronium und Atracurium. Anaesthesist 39: 96–100PubMedGoogle Scholar
  8. 8.
    Bailey DM, Nicholas ADG (1988) Comparison of atracurium and vecuronium during anaesthesia for laparoscopy. Br J Anaesth 61: 557–559PubMedCrossRefGoogle Scholar
  9. 9.
    Baraka A, Chaya L (1986) Hemodynamic effects of vecuronium in patients with coronary artery disease. Acta Anaesthesiol Scand 30: 28–29PubMedCrossRefGoogle Scholar
  10. 10.
    Barth L, Dannhorn R (1977) Protrahierte neuromuskuläre Wirkungen depolarisations- hemmender Muskelrelaxanzien, nachgewiesen mit der Tetanusreizantwort. Anaesthesist 26: 116–124PubMedGoogle Scholar
  11. 11.
    Barnes PK, Brindle-Smith G, White WD, Tennant R (1982) Comparison of the effects of ORG NC 45 and pancuronium bromide on heart rate and arterial pressure in anesthetized man. Br J Anaesth 54: 435–439PubMedCrossRefGoogle Scholar
  12. 12.
    Beemer GH, Dennis WL, Platt PR, Bjorksten AR, Carr AB (1988) Adverse reactions to atracurium and alcuronium. Br J Anaesth 61: 680–684PubMedCrossRefGoogle Scholar
  13. 13.
    Beemer GH, Bjorksten AR, Crankshaw DP (1990) Pharmacokinetics of atracurium during continuous infusion under fentanyl anesthesia. Anesthesiology 73: A904CrossRefGoogle Scholar
  14. 14.
    Beemer GH, Bjorksten AR, Crankshaw DP (1990) Pharmacokinetics of atracurium during continuous infusion. Br J Anaesth 65: 668–674PubMedCrossRefGoogle Scholar
  15. 15.
    Bencini AF, Houwertjes MC, Agoston S (1985) Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat. Br J Anaesth 57: 789–795PubMedCrossRefGoogle Scholar
  16. 16.
    Bencini AF, Scaf AHJ, Sohn YJ, Kersten-Kleef UW, Agoston S (1986) Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 58: 988–995PubMedCrossRefGoogle Scholar
  17. 17.
    Bencini AF, Scaf AHJ, Sohn YJ, Meistelman C, Lienhart A, Kersten UW, Schwarz S (1986) Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function or renal failure. Anesth Analg 65: 245–251PubMedCrossRefGoogle Scholar
  18. 18.
    Berntman L, Rösberg B, Shweikh I, Yousef H (1989) Atracurium and pancuronium in renal insufficiency. Acta Anaesthesiol Scand 33: 48–52PubMedCrossRefGoogle Scholar
  19. 19.
    Bevan DR, Archer I, Donati F, Ferguson A, Higgs BD (1982) Antagonism of pancuronium in renal failure: no recurarization. Br J Anaesth 54: 63–68PubMedCrossRefGoogle Scholar
  20. 20.
    Bevan DR, Donati F, Gyasi H, Williams A (1984) Vecuronium in renal failure. Can Anesth Soc J 31: 491–496CrossRefGoogle Scholar
  21. 21.
    Bevan JC, Donati F, Bevan DR (1985) Attempted acceleration of the onset of action of pancuronium. Br J Anaesth 57: 1204–1208PubMedCrossRefGoogle Scholar
  22. 22.
    Bevan DR, Smith CE, Donati F (1988) Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium and pancuronium. Anesthesiology 69: 272–276PubMedCrossRefGoogle Scholar
  23. 23.
    Bizzarri-Schmid MD, Desai SP (1986) Prolonged neuromuscular blockade with atracurium. Can Anaesth Soc J 33: 209–212PubMedCrossRefGoogle Scholar
  24. 24.
    Black AMS, Hutton P, El-Hassan KM, Morgan G, Clutton-Brock TH (1986) Priming and the onset of neuromuscular blockade with alcuronium. Br J Anaesth 58: 827–833PubMedCrossRefGoogle Scholar
  25. 25.
    Boulanger A, Hardy JF, Lepage Y (1990) Rapid induction sequence with vecuronium: should we intubate after 60 or 90 seconds? Can J Anaesth 37: 296–300PubMedCrossRefGoogle Scholar
  26. 26.
    Butterworth JF, Ray RJ, Dudas LM (1990) Priming before vecuronium: curare versus vecuronium. Anesthesiology 73: A907Google Scholar
  27. 27.
    Buzello W (1975) Der Stoffwechsel von Pancuronium beim Menschen. Anaesthesist 24: 13–18PubMedGoogle Scholar
  28. 28.
    Buzello W (1975) Der Konzentrationsverlauf des Pancuroniums im menschlichen Serum unter pharmakokinetischen Gesichtspunkten. Kongreßbericht über die Jahrestagung der DGAI 1974, Perimed Verlag, Erlangen. S 1256–1259Google Scholar
  29. 29.
    Buzello W, Agoston S (1978) Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium. Anaesthesist 27: 313–318PubMedGoogle Scholar
  30. 30.
    Buzello W, Agoston S (1978) Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Anaesthesist 27: 291–297PubMedGoogle Scholar
  31. 31.
    Caldwell JE, Robertson EN, Baird WLM (1986) Antagonism of vecuronium and atracurium at 5% twitch height recovery: neostigmine versus edrophonium. Anesthesiology 65: A289CrossRefGoogle Scholar
  32. 32.
    Caldwell JE, Castagnoli KP, Canfell PC, Fahey MR, Lynam DP, Fisher DM, Miller RD (1988) Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action. Br J Anaesth 61: 693–697PubMedCrossRefGoogle Scholar
  33. 33.
    Caldwell JE, Heier T, Miller RD (1989) Neuromuscular effects of neostigmine administered at 1, 2 or 3 hours after a single dose of vecuronium. Anesthesiology 71: A798Google Scholar
  34. 34.
    Casson WR, Jones RM, Skelly AM, Robinson PD, Adams AP (1985) Reversal of profound atracurium induced paralysis. Anti-cholinesterases compared using train of four stimulation. Anesthesiology 63: A360CrossRefGoogle Scholar
  35. 35.
    Coleman AJ, Downing JW, Lary WP, Moyes DG, Styles M (1972) The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man. Anaesthesia 27: 415–422PubMedCrossRefGoogle Scholar
  36. 36.
    Collins KM, Plantevin OM, Docherty PW (1984) Comparison of atracurium and alcuronium in day-case gynaecological surgery. Anaesthesia 39: 1130–1134PubMedCrossRefGoogle Scholar
  37. 37.
    Conil C, Bornet JL, Jean-Noel M, Conil JM, Brouchet A (1985) Choc anaphylactique au pancuronium et au vecuronium. Ann Fr Anesth Reanim 4: 241–243PubMedGoogle Scholar
  38. 38.
    Copman AF (1986) Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium and vecuronium steady-state infusions. Anesthesiology 65: 572–578CrossRefGoogle Scholar
  39. 39.
    Cozanitis DA, Erkola O (1989) A clinical study into the possible intrinsic bradycardic activity of vecuronium. Anaesthesia 44: 648–650PubMedCrossRefGoogle Scholar
  40. 40.
    Cozanitis DA, Lindgren L, Rosenberg PH (1989) Bradycardia in patients receiving atracurium or vecuronium in conditions of low vagal stimulation. Anaesthesia 44: 303–305PubMedCrossRefGoogle Scholar
  41. 41.
    Cronnelly R, Fisher DM, Miller RD, Gencarelli P, Nguyen-Gruenke L, Castagnoli N (1983) Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) and pancuronium in anesthetized humans. Anesthesiology 58: 405–408PubMedCrossRefGoogle Scholar
  42. 42.
    Cummings MF, Russell WJ, Frewin DB (1983) Effects of pancuronium and alcuronium on the changes in arterial pressure and plasma catecholamine concentrations during tracheal intubation. Br J Anaesth 55: 619–623PubMedCrossRefGoogle Scholar
  43. 43.
    D’Hollander A, Camu F, Sanders M (1978) Comparative evaluation of neuromuscular blockade after pancuronium administration in patients with and without renal failure. Acta Anaesth Scand 22: 21–26PubMedCrossRefGoogle Scholar
  44. 44.
    Dannemann H, Lübke P, Fritsche P, Boegl P (1972) Kardiovaskuläre Wirkungen von Alloferin während Valium-Kombinations- und Halothan-Narkosen. Anaesthesist 21: 391–393PubMedGoogle Scholar
  45. 45.
    Dernovoi BS, D’Hollander AA, Baurain MJ (1989) Antagonism of vecuronium by edrophonium: combined effect of doses and prereversal twitch height. Anesthesiology 71: A796CrossRefGoogle Scholar
  46. 46.
    Doherty WG, Breen PJ, Donati F, Bevan DR (1985) Accelerated onset of pancuronium with divided doses. Can Anaesth Soc J 32: 1–4PubMedCrossRefGoogle Scholar
  47. 47.
    Donati F (1989) Atracurium, pharmacokinetics and metabolites. Can J Anaesth 36: 257–261PubMedCrossRefGoogle Scholar
  48. 48.
    Donati F, Lahout J, Walsh CM, Lavelle PA, Bevan DR (1988) Onset of pancuronium and d-tubocurarine blockade with priming. Can Anaesth Soc J 33: 571–577CrossRefGoogle Scholar
  49. 49.
    Donati F, Meistelman C, Plaud B (1991) Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 74: 833–837PubMedCrossRefGoogle Scholar
  50. 50.
    Duvaldestin P, Agoston S, Henzel D, Kersten UW, Desmonts JM (1978) Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth 50: 1131–1136PubMedCrossRefGoogle Scholar
  51. 51.
    Engbaek JE, Andersen J (1990) The frequency of residual neuromuscular blockade following atracurium, vecuronium and pancuronium. A multicenter randomized study. Anesthesiology 73: A914Google Scholar
  52. 52.
    Ertama PM (1982) Histamine liberation in surgical patients following administration of neuromuscular blocking drugs. Annals of Clinical Research 14: 15–26PubMedGoogle Scholar
  53. 53.
    Fahey MR, Rupp SM, Fisher DM, Miller RD, Sharma M, Canfell C, Castagnoli K, Hennis PJ (1984) The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61: 699–702PubMedCrossRefGoogle Scholar
  54. 54.
    Farman JV, Turner JM, Blanloeil Y (1986) Atracurium infusion in liver transplantation. Br J Anaesth 58: 96S-102SGoogle Scholar
  55. 55.
    Fauvel NJ, Soni N (1989) Bradycardia associated with vecuronium. Anaesthesia 44: 1003PubMedCrossRefGoogle Scholar
  56. 56.
    Ferguson A, Egerszegi P, Bevan DR (1980) Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium. Anaesthesiology 53: 390–394CrossRefGoogle Scholar
  57. 57.
    Fisher DM, Rosen JI (1986) A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of non-depolarizing muscle relaxants. Anesthesiology 65: 286–291PubMedCrossRefGoogle Scholar
  58. 58.
    Fisher MM, Hallowes RC, Wilson RM (1978) Anaphylaxis to alcuronium. Anaesth Intensive Care 6: 125–128PubMedGoogle Scholar
  59. 59.
    Fisher DM, Canfell C, Fahey MR, Rosen JI, Rupp SM, Sheiner LB, Miller RD (1985) Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis. Anesthesiology 63: A310CrossRefGoogle Scholar
  60. 60.
    Foldes F (1984) Rapid tracheal intubation with non-depolarizing neuromuscular blocking drugs: the priming principle. Br J Anaesth 56: 663PubMedCrossRefGoogle Scholar
  61. 61.
    Foldes FF (1985) The priming principle. In: Agoston S, Bergmann H, Schwarz S, Steinbereithner K (Hrsg): Muskelrelaxanzien — Therapeutische Grenzen. Verlag Wilhelm Maudrich, Wien München Bern. S 113–120Google Scholar
  62. 62.
    Foldes FF, Nagashima H, Boros M, Tassonyi E, Fitzal S, Agoston S (1983) Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia. Br J Anaesth 55: 97S-103SCrossRefGoogle Scholar
  63. 63.
    Futter ME, Whalley DG, Wynands JE, Bevan DR (1983) Pancuronium requirement during hypothermic cardiopulmonary bypass in man. Anaesth Intensive Care: 216–219Google Scholar
  64. 64.
    Galletly DC (1986) Comparative cutaneous histamine release by neuromuscular blocking agents. Anaesth Intensive Care 14: 365–369PubMedGoogle Scholar
  65. 65.
    Galletly DC, Treuren BC (1985) Anaphylactoid reactions during anaesthesia. Anaesthesia 40: 329–333PubMedCrossRefGoogle Scholar
  66. 66.
    Gallo JA, Cork RC, Putschi P (1988) Comparison of effects of atracurium and vecuronium in cardiac surgical patients. Anesth Analg 67: 161–165PubMedCrossRefGoogle Scholar
  67. 67.
    Ginsberg B, Glass PS, Quill T, Shafron D, Ossey KD (1989) Onset and duration of neuromuscular blockades following high-dose vecuronium administration. Anesthesiology 71: 201–205PubMedCrossRefGoogle Scholar
  68. 68.
    Gordon KL, Reilly CS (1989) Recovery of neuromuscular function after infusion or intermittent bolus doses of atracurium or vecuronium. Br J Anaesth 62: 269–273PubMedCrossRefGoogle Scholar
  69. 69.
    Gramstad L (1987) Atracurium, vecuronium and pancuronium in end-stage renal failure. Br J Anaesth 59: 995–1003PubMedCrossRefGoogle Scholar
  70. 70.
    Gregoretti SM, Sohn YJ, Sia RL (1982) Heart rate and blood pressure changes after ORG NC 45 (vecuronium) and pancuronium during halothane and enflurane anesthesia. Anesthesiology 56: 392–395PubMedCrossRefGoogle Scholar
  71. 71.
    Günnicker M, Pohlen G, Hess W (1990) The influence of pancuronium and vecuronium combined with balanced anaesthesia on haemodynamics and myocardial oxygen balance. Acta Anaesthesiol Scand 34: 327–334PubMedCrossRefGoogle Scholar
  72. 72.
    Gyermek L, Lee C (1990) Reversal of pipecuronium and pancuronium induced neuromuscular block by edrophonium and pyridostigmine. Anesthesiology 73: A874Google Scholar
  73. 73.
    Hackl W, Plainer B, Mauritz W (1988) Protrahierte Vecuroniumwirkung bei einem Patienten mit dialysepflichtiger chronischer Niereninsuffizienz. Anaesthesist 37: 598–600PubMedGoogle Scholar
  74. 74.
    Haraldsted VY, Nielsen JW, Madsen JV, Hasselstroem L (1988) Maintenance of constant 95% neuromuscular blockade by adjustable infusion rates of pancuronium and atracurium. Br J Anaesth 60: 491–494PubMedCrossRefGoogle Scholar
  75. 75.
    Harper NJ, Bradshaw EG, Healy TE (1984) Antagonism of alcuronium with edrophonium or neostigmine. Br J Anaesth 56: 1089–1094PubMedCrossRefGoogle Scholar
  76. 76.
    Harrison GA (1972) The cardiovascular effects and some relaxant properties of four relaxants in patients about to undergo cardiac surgery. Br J Anaesth 44: 485–493PubMedCrossRefGoogle Scholar
  77. 77.
    Havill JH, Mee AD, Wallace MR, Chin LS, Rothwell RPG (1978) Prolonged curarisation in the presence of renal impairment. Anaesth Intensive Care 6: 234–238PubMedGoogle Scholar
  78. 78.
    Hawkins JL, Johnson TD, Kubicek MA, Skjonsby BS, Morrow DH, Joyce TH (1990) Vecuronium for rapid-sequence intubation for cesarean section. Anesth Analg 71: 185–190PubMedCrossRefGoogle Scholar
  79. 79.
    Haynes SR, Morton NS (1990) Prolonged neuromuscular blockade with vecuronium in a neonate with renal failure. Anaesthesia 45: 743–745PubMedCrossRefGoogle Scholar
  80. 80.
    Heier T, Caldwell JE, Sessler DI, Miller RD (1991) Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology 74: 815–819PubMedCrossRefGoogle Scholar
  81. 81.
    Hilgenberg JC, Stoelting RK, Harris WA (1983) Systemic vascular responses to atracurium during enflurane-nitrous-oxide anesthesia in humans. Anesthesiology 58: 242–244PubMedCrossRefGoogle Scholar
  82. 82.
    Höfer R, Krenn J, Pfeiffer G, Steinbereithner K (1969) Untersuchungen zur Ausscheidung von Diallyl-nor-Toxiferin bei Nierentransplantation. Der Anaesthesist 18: 304–308PubMedGoogle Scholar
  83. 83.
    Holt AW, Vedig AE (1988) Anaphylaxis following vecuronium. Anesth Intensive Care 16: 378–379Google Scholar
  84. 84.
    Hughes R, Payne JP (1979) Interaction of halothane with non-depolarizing neuromuscular blocking drugs in man. Br J Clin Pharmacol 7: 485–490PubMedGoogle Scholar
  85. 85.
    Hull CJ (1983) A model for atracurium? Br J Anaesth 55: 95–96PubMedCrossRefGoogle Scholar
  86. 86.
    Hull CJ, van Bem HBH, McLeod K, Sibbald A, Watson MJ (1978) A pharmacodynamic model for pancuronium. Br J Anaesth 50: 1113–1122PubMedCrossRefGoogle Scholar
  87. 87.
    Hunter JM, Jones RS, Utting JE (1982) Use of atracurium during general surgery monitored by the train-of-four stimuli. Br J Anaesth 54: 1243–1250PubMedCrossRefGoogle Scholar
  88. 88.
    Hunter JM, Jones RS, Utting JE (1984) Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth 56: 941–951PubMedCrossRefGoogle Scholar
  89. 89.
    Hunter JM, Parker CJR, Bell CF, Jones RS, Utting JE (1985) The use of different doses of vecuronium in patients with liver dysfunction. Br J Anaesth 57: 785–764Google Scholar
  90. 90.
    Inoue K, Reichelt W (1987) Combination of fentanyl, etomidate and vecuronium may cause severe vagotonic state. Br J Anaesth 59: 1475PubMedCrossRefGoogle Scholar
  91. 91.
    Inoue K, El-Banayosy A, Stolarski L, Reichelt W (1988) Vecuronium induced bradycardia following induction of anaesthesia with etomidate or thiopentone, with or without fentanyl. Br J Anaesth 60: 10–17PubMedCrossRefGoogle Scholar
  92. 92.
    Jelen-Esselborn S, Blobner M (1990) Wirkungsverstärkung von nichtdepolarisierenden Muskelrelaxanzien durch Nifedipin i.v. in Inhalationsanaesthesie. Anaesthesist 39: 173–178PubMedGoogle Scholar
  93. 93.
    Jones RM, Pearce AC, Williams JP (1984) Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium. Br J Anaesth 56: 453–457PubMedCrossRefGoogle Scholar
  94. 94.
    Kaushik S, Grover VK, Singh H, Yadav RVS (1984) Use of alcuronium in patients undergoing renal transplantation. Br J Anaesth 56: 1229–1233PubMedCrossRefGoogle Scholar
  95. 95.
    Kennedy BR, Kelman GR (1970) Cardiovascular effects of alcuronium in man. Br J Anaesth 42: 625–630PubMedCrossRefGoogle Scholar
  96. 96.
    Kristensen J, Helbo-Hansen HS, Toft P, Hole P (1989) The cardiovascular effects of vecuronium during halothane anaesthesia. Acta Anaesthesiol Scand 33: 494–497PubMedCrossRefGoogle Scholar
  97. 97.
    Kube D, Schuh FT (1985) Atracurium: Die neuromuskuläre Blockade bei wiederholter Gabe. Anaesthesist 34: 639–644PubMedGoogle Scholar
  98. 98.
    Lavery GG, Clarke RS J, Watkins J (1985) Histaminoid responses to atracurium, vecuronium and tubocurarine. Ann Fr Anesth Reanim 4: 180–183PubMedGoogle Scholar
  99. 99.
    Lee C, Mok MS, Barnes A, Katz RL (1977) Absence of „recurarization” in patients with demonstrated prolonged neuromuscular block. Br J Anaesth 49: 485–489PubMedCrossRefGoogle Scholar
  100. 100.
    Lepage JY, Malinge M, Cozian A, Pinaut M, Blanloeil Y, Souron R (1987) Vecuronium and atracurium in patients with end-stage renal failure. Br J Anaesth 59: 1004–1010PubMedCrossRefGoogle Scholar
  101. 101.
    Leuwer M, Klein G (1988) Wiederholte Injektion von Atracurium zur Muskelrelaxation bei abdominalchirurgischen Eingriffen. Anaesth Intensivther Notfallmed 23: 291–296CrossRefGoogle Scholar
  102. 102.
    Markschies-Hornung A, Woroszylski F, Schulte-Sasse U, Tarnow J (1985) Untersuchungen der Kreislaufwirkungen von Vecuronium sowie von Pancuronium unter verschiedenen Anästhesiebedingungen. Anaesth Intensivther Notfallmed 20: 57–61CrossRefGoogle Scholar
  103. 103.
    Mellinghoff H, Diefenbach C, Buzello W (1991) Auswahlkriterien für den Einsatz von Muskelrelaxanzien. Anaesthesist 40: S241Google Scholar
  104. 104.
    Meretoja OA, Brown TC, Clare D (1990) Dose response of alcuronium and d-tubocurarine in infants, children and adolescents. Anaesth Intensive Care 18: 449–451PubMedGoogle Scholar
  105. 105.
    Miller RD (1986) Pharmacokinetics of atracurium and other non-depolarising neuromuscular blocking agents in normal patients and those with renal or hepatic dysfunction. Br J Anaesth 58: 11S-13SCrossRefGoogle Scholar
  106. 106.
    Miller RD, Cullen DJ (1976) Renal failure and postoperative respiratory failure: Recurarization? Br J Anaesth 48: 253–256PubMedCrossRefGoogle Scholar
  107. 107.
    Miller RD, Agoston S, Booij LH, Kersten UW, Crul JF, Ham J (1978) The comparative potency and pharmacokinetics of pancuronium and its metabolites in anesthetized man. J Pharmacol Exp Ther 207: 539–543PubMedGoogle Scholar
  108. 108.
    Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ (1984) Clinical pharmacology of vecuronium and atracurium. Anesthesiology 61: 444–453PubMedCrossRefGoogle Scholar
  109. 109.
    Moneret-Vautrin DA, Mouton C, Widmer S (1985) Anaphylaxie aux myorelaxants. Valeur prédictive des intradermoreactions et recherche de l’anaphylaxie croisée. Ann Fr Anesth Réanim 4: 186–191PubMedGoogle Scholar
  110. 110.
    Morris RB, Cahalan MK, Miller RD, Wilkinson PL, Quasha AL, Robinson SL (1983) The cardiovascular effects of vecuronium (ORG NC 45) and pancuronium in patients undergoing coronary artery bypass grafting. Anesthesiology 58: 438–440PubMedCrossRefGoogle Scholar
  111. 111.
    Mötsch J, Hennis PJ, Zimmermann FA, Agoston S (1989) A model for determining the influence of hepatic uptake of non-depolarizing muscle relaxants in the pig. Anesthesiology 70: 128–133PubMedCrossRefGoogle Scholar
  112. 112.
    Naguib M (1989) Anaphylactoid reactions following propofol-atracurium sequence. Can J Anaesth 36: 358–359CrossRefGoogle Scholar
  113. 113.
    O’Hara DA, Derbyshire GJ, Overdyk FJ, Bogen DK, Marshall BE (1991) Closed-loop infusion of atracurium with four different anesthetic techniques. Anesthesiology 74: 258–263PubMedCrossRefGoogle Scholar
  114. 114.
    O’Kelly B, Jayais P, Veroli P, Lhuissier C, Ecoffey C (1990) Vecuronium or atracurium for orthotopic liver transplantation. Anesthesiology 73: A905CrossRefGoogle Scholar
  115. 115.
    Oh TE, Horton JM (1989) Adverse reactions to atracurium. Br J Anaesth 62: 467–470PubMedCrossRefGoogle Scholar
  116. 116.
    Öhquvist G, Settergren G, Tuppurainen T, Lindskog EA, Fischerström A, Torsseli L, Wedelin B, Wickerts CJ (1985) Circulatory effects of pancuronium and alcuronium in patients with coronary artery stenosis. Acta Anaesthesiol Scand 29: 22–25CrossRefGoogle Scholar
  117. 117.
    Ohta Y (1985) Paradoxical antagonism of neuromuscular block by vecuronium metabolites. Acta Med Okayama 39: 471–480PubMedGoogle Scholar
  118. 118.
    Orko R, Heino A, Rosenberg PH (1985) Vecuronium in patients with and without renal failure. Acta Anaesthesiol Scand 29: 326–329PubMedCrossRefGoogle Scholar
  119. 119.
    Orko R, Heino A, Bjôrkstén F, Scheinin B, Rosenberg PH (1987) Comparison of atracurium and vecuronium in anaesthesia for renal transplantation. Acta Anaesthesiol Scand 31: 450–453PubMedCrossRefGoogle Scholar
  120. 120.
    Patriarca G, Nucera E, Schiavino D, Romano A, di Rienzo V, Pellegrino S, Fais G (1989) Pancuronium allergy: a case report. Br J Anaesth 62: 210–212PubMedCrossRefGoogle Scholar
  121. 121.
    Parker CJR, Hunter JM (1989) Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Br J Anaesth 62: 177–183PubMedCrossRefGoogle Scholar
  122. 122.
    Pauca AL, Skovsted P (1981) Cardiovascular effects of pancuronium in patients anaesthetized with enflurane and fluroxene. Can Anaesth Soc J 28: 39–45PubMedCrossRefGoogle Scholar
  123. 123.
    Pedersen T, Viby-Mogensen J, Bang U, Olsen NV, Jensen E, Engbaek J (1990) Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? Anesthesiology 73: 835–839PubMedCrossRefGoogle Scholar
  124. 124.
    Peschaud JL, Kienlen J, Rey G, Marres F, Momas I, D’Athis F, du Cailar J (1990) Pharmacodynamics of vecuronium in patients with and without renal failure. Anesthesiology 73: A916CrossRefGoogle Scholar
  125. 125.
    Pevny I, Danhauser I (1981) Anaphylactic shock during general anaesthesia due to fentanyl and alloferin in a patient with positive skin test. Anaesthesist 30: 400–404PubMedGoogle Scholar
  126. 126.
    Philbin DM, Machaj VR, Tomichek RC, Schneider RC, Alban JC, Lowenstein E, Lineberry CC (1983) Haemodynamic effects of bolus injections of atracurium in patients with coronary artery disease. Br J Anaesth 55: 131S-134SCrossRefGoogle Scholar
  127. 127.
    Pittet JF, Tassonyi E, Schopfer C, Morel DR, Mentha G, Fathi M, le Coultre C, Steinig DA, Benakis A (1990) Plasma concentrations of laudanosine, but not of atracurium, are increased during the anhepatic phase of orthotopic liver transplantation. Anesthesiology 72: 145–152PubMedCrossRefGoogle Scholar
  128. 128.
    Pollard BJ (1989) Priming with alcuronium and tubocurarine accelerates the onset of neuromuscular block. Br J Anaesth 63: 7–11PubMedCrossRefGoogle Scholar
  129. 129.
    Power SJ, Jones RM (1989) Reversal of profound paralysis: use of large doses of edrophonium to antagonize vecuronium and pancuronium neuromuscular blockade. Acta Anaesthesiol Scand 33: 478–481PubMedCrossRefGoogle Scholar
  130. 130.
    Pühringer F, Adler R, Mitterschiffthaler G, Koller J, Mair P, Kühnl-Brady KS, Agoston S (1990) Dosis-Wirkungs-Beziehung und Zeitverlauf der neuromuskulären Blockade von Alcuronium. Anaesthesist 39: 508–512PubMedGoogle Scholar
  131. 131.
    Pusey JM, Charlton SM, Skinner JB, Assem ESK (1987) Anaphylactoid reaction to alcuronium. Anaesthesia 42: 164–167PubMedCrossRefGoogle Scholar
  132. 132.
    Qvist TF, Lang-Jensen T, Korshin JD, Skovsted P (1980) The cardiovascular effects of pancuronium during halothane and cyclopropane anaesthesia. Acta Anaesthesiol Scand 24: 415–418PubMedCrossRefGoogle Scholar
  133. 133.
    Raaflaub J, Frey P (1972) Zur Pharmakokinetik von Diallyl-nor-toxiferin beim Menschen. Arzneim-Forsch 22: 73–78Google Scholar
  134. 134.
    Riegler R, Fitzal S (1984) Beeinflussung des Kreislaufverhaltens unter ORG NC 45 (Norcuron) bei drei verschiedenen Narkoseverfahren an kardial gesunden Patienten. Anaesthesist 33: 363–365PubMedGoogle Scholar
  135. 135.
    Riemer I (1985) Intubation und nicht-depolarisierende Muskelrelaxanzien. In: Agoston S, Bergmann H, Schwarz S, Steinbereithner K (Hrsg) Muskelrelaxanzien — Therapeutische Grenzen. Verlag Wilhelm Maudrich, Wien München BernGoogle Scholar
  136. 136.
    Roervik K, Husby P, Gramstad L, Vamnes JS, Bitsch-Larsen L, Koller ME (1988) Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade. Br J Anaesth 61: 180–185CrossRefGoogle Scholar
  137. 137.
    Roizen MF, Feeley TW (1978) Pancuronium bromide. Annals of Internal Medicine 88: 64–68PubMedGoogle Scholar
  138. 138.
    Salmenperä M, Peltola K, Takkunen O, Heinonen J (1983) Cardiovascular effects of pancuronium and vecuronium during high-dose fentanyl anesthesia. Anesth Analg 62: 1055–1058Google Scholar
  139. 139.
    Schaer H (Hrsg) (1972) Kreislaufwirkungen von nichtdepolarisierenden Muskelrelaxanzien. Reihe: Anaesthesiologie und Wiederbelebung. Springer-Verlag, Berlin Heidelberg New York, Band 63: 1–51Google Scholar
  140. 140.
    Schaer H, Baasch K, Nassehi R (1984) Vergleichende klinische Untersuchungen über Vecuronium, Atracurium und Pancuronium. Anaesthesist 33: 259–265PubMedGoogle Scholar
  141. 141.
    Schönstedt R, Stubbig K, Martin E (1991) Einsatzmöglichkeiten moderner Muskelrelaxanzien — Bolus versus Infusion. Anaesthesist 40: S243Google Scholar
  142. 142.
    Schönstedt R, Bauer H, Stubbig K, Bohrer H (1991) Steuerung der neuromuskulären Blockade durch kontinuierliche Atracurium-Infusion — Vorteile gegenüber Repetitions- gaben. Anaesthesist 40: S262Google Scholar
  143. 143.
    Schwarz S, Ilias W, Lackner F, Mayrhofer O, Foldes F (1985) Rapid tracheal intubation with vecuronium: the priming principle. Anesthesiology 62: 388–391PubMedCrossRefGoogle Scholar
  144. 144.
    Schwarz S, Lackner FX, Hrska F, Weindlmayr-Goettel M, Tüchy G, Steinbereithner K (1990) Metabolism of atracurium in patients with renal failure. Anesthesiology 73: A917CrossRefGoogle Scholar
  145. 145.
    Scott RPF, Goat VA (1982) Atracurium: its speed of onset. A comparison with suxamethonium. Br J Anaesth 54: 909–911PubMedCrossRefGoogle Scholar
  146. 146.
    Shanks CA (1986) Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. Anesthesiology 64: 72–86PubMedCrossRefGoogle Scholar
  147. 147.
    Shanks CA, Walker JS, Ramzan MI, Triggs EJ (1981) Dose-response curves for four neuromuscular blockers using continuous i.v. infusion. Br J Anaesth 53: 627–633PubMedCrossRefGoogle Scholar
  148. 148.
    Sher MH, Mathews PA (1983) Recurarization with Quinine administration after reversal from anaesthesia. Anaesth Intensive Care 11: 241–243PubMedGoogle Scholar
  149. 149.
    Simpson DS, Souter AJ (1990) A computer designed graph for administration of atracurium by i.V. infusion. Br J Anaesth 65: 770–778PubMedCrossRefGoogle Scholar
  150. 150.
    Sleigh JW, Matheson KH (1984) The use of atracurium besylate for laparoscopy. Anaesthesia 39: 277–279PubMedCrossRefGoogle Scholar
  151. 151.
    Sohn YJ, Bencini AF, Scaf AHJ, Kersten UW, Agoston S (1986) Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients. Anesth Analg 65: 233–239PubMedCrossRefGoogle Scholar
  152. 152.
    Sold M, Lazarus G, Baar H (1987) Antagonism of an intubation dose of vecuronium. Anaesthesist 36: 345–351PubMedGoogle Scholar
  153. 153.
    Somogyi AA, Shanks CA, Triggs EJ (1976) Clinical pharmacokinetics of pancuronium bromide. Europ J Clin Pharmacol 10: 367–372CrossRefGoogle Scholar
  154. 154.
    Somogyi AA, Shanks CA, Triggs EJ (1977) Disposition kinetics of pancuronium bromide in patients with total biliary obstruction. Br J Anaesth 49: 1103–1108PubMedCrossRefGoogle Scholar
  155. 155.
    Sosis M, Larijani GE, Marr AT (1987) Priming with atracurium. Anesth Analg 66 (7): 329–332PubMedCrossRefGoogle Scholar
  156. 156.
    Stanley JC, Mirakhur RK (1989) Comparative potency of pipecuronium bromide and pancuronium bromide. Br J Anaesth 63: 754–755PubMedCrossRefGoogle Scholar
  157. 157.
    Starsnic MA, Goldberg ME, Ritter DE, Marr AT, Sosis M, Larijani GE (1989) Does vecuronium accumulate in the renal transplant patient? Can J Anaesth 36: 35–39PubMedCrossRefGoogle Scholar
  158. 158.
    Staun P, Lennmarken C (1988) Experience of multiple supplementary doses of vecuronium. Acta Anaesthesiol Scand 32: 156–157PubMedCrossRefGoogle Scholar
  159. 159.
    Tassonyi E, Gaumann D, Polla B (1991) Atracurium: Nebenwirkungen und Histaminfreisetzung. Anaesthesist 40: S242Google Scholar
  160. 160.
    Torsher L, Martineau RJ, Hull KA, Miller DR (1990) A comparison of the hemodynamic effects of atracurium and vecuronium during anaesthetic induction. Can J Anaesth 37: S142Google Scholar
  161. 161.
    Tryba M, Triene M, Wruck G, Zenz M (1988) Kardiovaskuläre Reaktionen und Histaminfreisetzung nach Atracurium — ein Problem der Dosis? Anaesthesist 37: 483–488PubMedGoogle Scholar
  162. 162.
    Tullock WC, Diana P, Cook DR, Wilks DH, Brandom BW, Stiller RL, Beach CA (1990) Neuromuscular and cardiovascular effects of high-dose vecuronium. Anesth Analg 70: 86–90PubMedCrossRefGoogle Scholar
  163. 163.
    Vandenbrom RHG, Wierda JMKH, Agoston S (1990) Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokinet 19: 230–240PubMedCrossRefGoogle Scholar
  164. 164.
    Waldmann CS, Wark KJ, Sebel PS, Feneck RO (1986) Hemodynamic effects of atracurium, vecuronium and pancuronium during sufentanil anesthesia for coronary artery bypass. Acta Anaesthesiol Scand 30: 351–356PubMedCrossRefGoogle Scholar
  165. 165.
    Walker J, Shanks CA, Triggs EJ (1980) Clinical pharmacokinetics of alcuronium chloride in man. Eur J Clin Pharmacol 17: 449–457PubMedCrossRefGoogle Scholar
  166. 166.
    Walker JS, Shanks C, Brown KF (1983) Alcuronium kinetics and plasma concentration- effect relationship. Clin Pharmacol Ther 33: 510–516PubMedCrossRefGoogle Scholar
  167. 167.
    Walts LF, Dillon JB (1968) Durations of action of d-tubocurarine and gallamine. Anesthesiology 29: 499–504PubMedCrossRefGoogle Scholar
  168. 168.
    Ward S, Neill EAM (1983) Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth 55: 1169–1172PubMedCrossRefGoogle Scholar
  169. 169.
    Ward S, Boheimer N, Weatherley BC, Simmonds RJ, Dopson TA (1987) Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients with renal failure. Br J Anaesth 59: 697–706PubMedCrossRefGoogle Scholar
  170. 170.
    Watkins J (1986) Histamine release and atracurium. Br J Anaesth 58: 19S-22SGoogle Scholar
  171. 171.
    Watkins J (1989) Second report from an anaesthetic reactions advisory service. Anaesthesia 44: 157–159PubMedCrossRefGoogle Scholar
  172. 172.
    Weinstein JA, Matteo RS, Ornstein E, Schwartz AE, Goldstoff M, Thal G (1988) Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg 67: 1149–1153PubMedCrossRefGoogle Scholar
  173. 173.
    Westra P, Vermeer GA, de Lange AR, Scaf AH, Meijer DK, Wesseling H (1981) Hepatic and renal disposition of pancuronium and gallamine in patients with extrahepatic cholestasis. Br J Anaesth 53: 331–338PubMedCrossRefGoogle Scholar
  174. 174.
    Wierda JMKH, Maestrone E, Bencini AF, Boyer A, Rashkovsky OM, Lip H, Karliczek R, Ket JM, Agoston S (1989) Haemodynamic effects of vecuronium. Br J Anaesth 62: 194–198PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag GmbH & Co. 1994

Authors and Affiliations

  • A. Frey
    • 1
    • 2
  1. 1.Medizinische Hochschule HannoverDeutschland
  2. 2.Lehrstuhl für AnaesthesiologieUniversitätsklinikumRegensburgDeutschland

Personalised recommendations